Arkolith/Insider Trading/CMMB/Form 4

Nicaise Claude

DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2023Grant(A)12K—$012K
Mar 16, 2023Grant(A)7K—$07K
Mar 16, 2023Grant(A)7K—$07K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-23-001113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML